John Flavin
Founder at PYXIS ONCOLOGY, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
John L.
Flavin is the founder and currently holds the position of Chairman at Pyxis Oncology, Inc., which was founded in 2018.
He is also the CEO at Portal Innovations LLC, which was founded in 2020.
In addition to his founding positions, Mr. Flavin currently serves as the Executive Chairman at ClostraBio, Inc. and as the Manager at Flavin Ventures LLC.
Previously, Mr. Flavin held the position of Chief Executive Officer at Emerald BioStructures, Inc., ThermoGen, Inc., and Advanced X-Ray Analytical Services, Inc. He also served as the President, CFO, Secretary & Director at Advanced Life Sciences Holdings, Inc. from 2002 to 2011.
Prior to that, he was the Chief Operating Officer at MediChem Life Sciences, Inc. from 1991 to 2002.
From 2018 to 2020, he served as the Chief Financial Officer at Endotronix, Inc.Mr. Flavin completed his undergraduate degree at Marquette University in 1991 and obtained an MBA from Lewis University in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC.
0.71% | 2024-03-25 | 413,015 ( 0.71% ) | 2 M $ | 2024-04-29 |
John Flavin active positions
| Companies | Position | Start |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Founder | 2018-06-10 |
| Flavin Ventures LLC | Corporate Officer/Principal | 2010-01-03 |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Chief Executive Officer | 2022-02-28 |
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Chairman | - |
Former positions of John Flavin
| Companies | Position | End |
|---|---|---|
Endotronix, Inc.
 Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Director of Finance/CFO | 2020-01-31 |
| ADVANCED LIFE SCIENCES HOLDINGS, INC. | President | 2011-05-04 |
MediChem Life Sciences, Inc.
 MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The private company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | President | 2000-04-30 |
| Advanced X-Ray Analytical Services, Inc. | President | - |
ThermoGen, Inc.
 ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | President | - |
Training of John Flavin
| Lewis University | Masters Business Admin |
| Marquette University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PYXIS ONCOLOGY, INC. | Health Technology |
| Private companies | 9 |
|---|---|
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The private company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Advanced Life Sciences Holdings, Inc.
 Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a private company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
| Flavin Ventures LLC | |
| Advanced X-Ray Analytical Services, Inc. | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
- Stock Market
- Insiders
- John Flavin
